BDBM227715 US9556170, 2
SMILES: CN1CCN(CC1)S(=O)(=O)c1ccc2[nH]c(Nc3cc(Cl)ccc3O)nc2c1
InChI Key: InChIKey=WYWUOCBVOUFBDY-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lysine-specific histone demethylase 1A (Homo sapiens (Human)) | BDBM227715 (US9556170, 2) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 273 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Utah Research Foundation US Patent | Assay Description Inhibition of LSD activity can be determined by a variety of both in vitro and in vivo methods known to one skilled in the art. For example, enzymati... | US Patent US9556170 (2017) BindingDB Entry DOI: 10.7270/Q2GX4DJX | |||||||||||
More data for this Ligand-Target Pair |